RxDoctor Payments DataLook up a doctor →

Dennis Levinson

Internal Medicine · Chicago, ILNPI 1720050016

Payments from drug & device makers

$25,338,226in general payments, 2019–2025

Across 883 payments — averaging $28,696 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Regeneron$9.3M
  • AstraZeneca$7.7M
  • Novartis$2.2M
  • Astrazeneca UK Limited$1.3M
  • AbbVie$993K
  • Pfizer$908K
  • plus $2.9M from 17 others
$138,255in research payments, 2019–2025

Across 6 payments — averaging $23,043 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Eli Lilly$137K
  • Pfizer$1K

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Regeneron238$9,287,525
AstraZeneca6$7,709,028
Novartis35$2,157,536
Astrazeneca UK Limited3$1,345,525
AbbVie68$993,247
Pfizer93$908,001
Amgen14$713,988
Modernatx, Inc.129$690,114
Eli Lilly3$356,874
Sumitomo Pharma America, Inc.33$298,055
Argenx US, Inc.128$231,758
Organogenesis Inc.10$164,530
GRT US Holding, Inc.34$143,718
Astellas Pharma Global Development34$134,009
Merck8$76,875
GSK15$56,854
Sanofi US Services Inc.10$40,504
UCB SA3$29,833
Biogen14$136
Mallinckrodt Enterprises LLC2$48
Boehringer Ingelheim1$33
Antares Pharma, Inc.1$21
Johnson & Johnson1$16

How this compares

$25,338,226 in reported general payments places this provider in the 95th percentile of 5,182 internal medicine providers in Illinois.

See all internal medicine providers in Illinois

Other internal medicine in Chicago

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →